Browse the complete record of transactions filed by Ginocchio Paul, Chief Financial Officer. Insider active across 2 companies, notably Augmedix, Inc.. In total, 11 disclosures have been published. Total volume traded: €570k. The latest transaction was disclosed on 26 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Paul Ginocchio is the Chief Financial Officer at Augmedix, Inc. He is responsible for the company's financial management, overseeing accounting and financial operations. His role is crucial in ensuring the financial health of the company and supporting strategic decision-making. He brings his expertise in finance and management to guide the company's activities.